drugset / Trial / NCT02221882
A Study of LY3164530 in Participants With Cancer
NaSingle-groupOpen-labelTreatment
Summary
The main purpose of this study is to evaluate the safety of a study drug known as LY3164530 in participants with cancer that is advanced and/or has spread to another part(s) of the body.
Timeline
- Start
- 2014-08
- Primary completion
- 2017-03-07
- Completion
- 2017-03-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LY3164530 | Unknown | — | Intravenous |